Today

Biogen Financial News

All news where Biogen is mentioned

Biogen falls as earnings, revenue misses consensus

Biogen falls as earnings, revenue misses consensus

European committee says Alzheimer's treatment Leqembi shouldn't get marketing approval

European committee says Alzheimer's treatment Leqembi shouldn't get marketing approval

FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer's drug

FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer's drug

The margin of safety: the ten-billion-dollar lesson from Amgen

The margin of safety: the ten-billion-dollar lesson from Amgen

This week in earnings: Coinbase jumps on strong beat, Coca-Cola hikes dividend

This week in earnings: Coinbase jumps on strong beat, Coca-Cola hikes dividend

Midday movers: Hasbro and Avis slip; Ecolab rises

Midday movers: Hasbro and Avis slip; Ecolab rises

AM Green partners Envision Energy for wind turbines, green hydrogen projects

AM Green partners Envision Energy for wind turbines, green hydrogen projects

Keppel and AM Green to explore sustainable fuel production in South-east Asia, Middle East

Keppel and AM Green to explore sustainable fuel production in South-east Asia, Middle East

Dr Reddy’s capex likely at ₹700 cr in H2: CMD Prasad

Dr Reddy’s capex likely at ₹700 cr in H2: CMD Prasad

Wall St extends winning streak; eyes Fed speakers, Treasury auctions

Wall St extends winning streak; eyes Fed speakers, Treasury auctions

Dow Jones, Nasdaq, S&P 500 weekly preview: Fed sparks a massive rally

Dow Jones, Nasdaq, S&P 500 weekly preview: Fed sparks a massive rally

Blood tests needed for widespread Alzheimer's diagnosis on the way

Blood tests needed for widespread Alzheimer's diagnosis on the way

PE Advent completes acquisition of Suven Pharma, appoints new Board and management team

PE Advent completes acquisition of Suven Pharma, appoints new Board and management team

After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen

After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen

Dr Reddy's Laboratories jumps into the fray for Biogen's biosimilars

Dr Reddy's Laboratories jumps into the fray for Biogen's biosimilars

Intas eyes Biogen’s biosimilars for $1 bn

Intas eyes Biogen’s biosimilars for $1 bn

Experimental blood test may be able to detect Parkinson's disease-related DNA damage, says study

Experimental blood test may be able to detect Parkinson's disease-related DNA damage, says study

What happens when a $2 million gene therapy is not enough

What happens when a $2 million gene therapy is not enough

The first pill to treat postpartum depression has been approved by US health officials

The first pill to treat postpartum depression has been approved by US health officials

Sage tumbles to record low on clinical depression pill setback

Sage tumbles to record low on clinical depression pill setback

The first pill to treat postpartum depression has been approved by US health officials

The first pill to treat postpartum depression has been approved by US health officials

1
2
3
Next

About Us

Fvbb.com is an aggregator of the latest financial news in your feed. Be the first to know everything concerning financial analyzes, currency, world economy, investments and even much more. The latest financial news from the leading news agencies around the world at one place for your comfort. 300+ information resources are here on our site, that give you the opportunity to save time on search. Just actual news 24/7 non-stop! Stay tuned and we will keep you informed!

Owner: SNOWLAND s.r.o.
Registration certificate 06691200
Address:
Snowland s.r.o.
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6
Czech Republic

Categories

Info

For advertisers

Advertising Questions ?

Add news

Add Source

©2024. All rights reserved.

DMCA